Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders

Annamaria Vallelunga, Raffaella Flaibani, Patrizia Formento-Dojot, Roberta Biundo, Silvia Facchini, Angelo Antonini

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: The mechanisms underlying the development of impulse control disorders (ICDs) like compulsive gambling, buying, sexual, and eating behaviors in Parkinson's disease (PD) are debated. We assessed whether allelic variants of dopamine D2 receptors (DRD2), catechol-O-methyltransferase (COMT) and dopamine transporter (DAT) were associated with the development of ICDs in PD. Method: We enrolled 89 idiopathic PD patients (48 without ICDs and 41 with ICDs). All patients were screened with the Minnesota Impulsive Disorders Interview (MIDI) and fulfilled DSM-IV criteria for the ICD positive cohort. Differences in the frequency of the genotypes between ICDs and non-ICDs groups were assessed using the χ 2 test. Results: Genotyping was performed for variants of the DRD2 Taq1A (rs1800497), COMT Val 158Met (rs4680), DAT1 (3' UTR 40bp VNTR). Variants of DRD2 Taq1A, COMT and DAT1 were not associated with the risk of developing ICDs. Conclusion: In our study, there were no differences in the frequency of variant of DRD2 Taq1A, COMT and DAT1 between the two groups. Polymorphisms of dopaminergic genes do not play a relevant role in the development of ICD in PD suggesting that ICD originate from inability to filter inappropriate behaviors triggered by dopaminergic therapy.

Original languageEnglish
Pages (from-to)397-399
Number of pages3
JournalParkinsonism and Related Disorders
Volume18
Issue number4
DOIs
Publication statusPublished - May 2012

Fingerprint

Disruptive, Impulse Control, and Conduct Disorders
Genetic Polymorphisms
Parkinson Disease
Catechol O-Methyltransferase
Gambling
Dopamine Plasma Membrane Transport Proteins
Dopamine D2 Receptors
3' Untranslated Regions
Feeding Behavior
Diagnostic and Statistical Manual of Mental Disorders
Sexual Behavior
Genotype
Interviews

Keywords

  • COMT
  • DAT1
  • Dopamine agonist
  • Dopaminergic therapy
  • DRD2
  • Genetic
  • Impulse control disorder
  • Levodopa
  • Mechanisms
  • Parkinson disease
  • Pramipexole
  • Ropinirole
  • Taq1A

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology

Cite this

Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders. / Vallelunga, Annamaria; Flaibani, Raffaella; Formento-Dojot, Patrizia; Biundo, Roberta; Facchini, Silvia; Antonini, Angelo.

In: Parkinsonism and Related Disorders, Vol. 18, No. 4, 05.2012, p. 397-399.

Research output: Contribution to journalArticle

Vallelunga, Annamaria ; Flaibani, Raffaella ; Formento-Dojot, Patrizia ; Biundo, Roberta ; Facchini, Silvia ; Antonini, Angelo. / Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders. In: Parkinsonism and Related Disorders. 2012 ; Vol. 18, No. 4. pp. 397-399.
@article{25afbf40c3284750a9cc9d7b3c98a6a5,
title = "Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders",
abstract = "Background: The mechanisms underlying the development of impulse control disorders (ICDs) like compulsive gambling, buying, sexual, and eating behaviors in Parkinson's disease (PD) are debated. We assessed whether allelic variants of dopamine D2 receptors (DRD2), catechol-O-methyltransferase (COMT) and dopamine transporter (DAT) were associated with the development of ICDs in PD. Method: We enrolled 89 idiopathic PD patients (48 without ICDs and 41 with ICDs). All patients were screened with the Minnesota Impulsive Disorders Interview (MIDI) and fulfilled DSM-IV criteria for the ICD positive cohort. Differences in the frequency of the genotypes between ICDs and non-ICDs groups were assessed using the χ 2 test. Results: Genotyping was performed for variants of the DRD2 Taq1A (rs1800497), COMT Val 158Met (rs4680), DAT1 (3' UTR 40bp VNTR). Variants of DRD2 Taq1A, COMT and DAT1 were not associated with the risk of developing ICDs. Conclusion: In our study, there were no differences in the frequency of variant of DRD2 Taq1A, COMT and DAT1 between the two groups. Polymorphisms of dopaminergic genes do not play a relevant role in the development of ICD in PD suggesting that ICD originate from inability to filter inappropriate behaviors triggered by dopaminergic therapy.",
keywords = "COMT, DAT1, Dopamine agonist, Dopaminergic therapy, DRD2, Genetic, Impulse control disorder, Levodopa, Mechanisms, Parkinson disease, Pramipexole, Ropinirole, Taq1A",
author = "Annamaria Vallelunga and Raffaella Flaibani and Patrizia Formento-Dojot and Roberta Biundo and Silvia Facchini and Angelo Antonini",
year = "2012",
month = "5",
doi = "10.1016/j.parkreldis.2011.10.019",
language = "English",
volume = "18",
pages = "397--399",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders

AU - Vallelunga, Annamaria

AU - Flaibani, Raffaella

AU - Formento-Dojot, Patrizia

AU - Biundo, Roberta

AU - Facchini, Silvia

AU - Antonini, Angelo

PY - 2012/5

Y1 - 2012/5

N2 - Background: The mechanisms underlying the development of impulse control disorders (ICDs) like compulsive gambling, buying, sexual, and eating behaviors in Parkinson's disease (PD) are debated. We assessed whether allelic variants of dopamine D2 receptors (DRD2), catechol-O-methyltransferase (COMT) and dopamine transporter (DAT) were associated with the development of ICDs in PD. Method: We enrolled 89 idiopathic PD patients (48 without ICDs and 41 with ICDs). All patients were screened with the Minnesota Impulsive Disorders Interview (MIDI) and fulfilled DSM-IV criteria for the ICD positive cohort. Differences in the frequency of the genotypes between ICDs and non-ICDs groups were assessed using the χ 2 test. Results: Genotyping was performed for variants of the DRD2 Taq1A (rs1800497), COMT Val 158Met (rs4680), DAT1 (3' UTR 40bp VNTR). Variants of DRD2 Taq1A, COMT and DAT1 were not associated with the risk of developing ICDs. Conclusion: In our study, there were no differences in the frequency of variant of DRD2 Taq1A, COMT and DAT1 between the two groups. Polymorphisms of dopaminergic genes do not play a relevant role in the development of ICD in PD suggesting that ICD originate from inability to filter inappropriate behaviors triggered by dopaminergic therapy.

AB - Background: The mechanisms underlying the development of impulse control disorders (ICDs) like compulsive gambling, buying, sexual, and eating behaviors in Parkinson's disease (PD) are debated. We assessed whether allelic variants of dopamine D2 receptors (DRD2), catechol-O-methyltransferase (COMT) and dopamine transporter (DAT) were associated with the development of ICDs in PD. Method: We enrolled 89 idiopathic PD patients (48 without ICDs and 41 with ICDs). All patients were screened with the Minnesota Impulsive Disorders Interview (MIDI) and fulfilled DSM-IV criteria for the ICD positive cohort. Differences in the frequency of the genotypes between ICDs and non-ICDs groups were assessed using the χ 2 test. Results: Genotyping was performed for variants of the DRD2 Taq1A (rs1800497), COMT Val 158Met (rs4680), DAT1 (3' UTR 40bp VNTR). Variants of DRD2 Taq1A, COMT and DAT1 were not associated with the risk of developing ICDs. Conclusion: In our study, there were no differences in the frequency of variant of DRD2 Taq1A, COMT and DAT1 between the two groups. Polymorphisms of dopaminergic genes do not play a relevant role in the development of ICD in PD suggesting that ICD originate from inability to filter inappropriate behaviors triggered by dopaminergic therapy.

KW - COMT

KW - DAT1

KW - Dopamine agonist

KW - Dopaminergic therapy

KW - DRD2

KW - Genetic

KW - Impulse control disorder

KW - Levodopa

KW - Mechanisms

KW - Parkinson disease

KW - Pramipexole

KW - Ropinirole

KW - Taq1A

UR - http://www.scopus.com/inward/record.url?scp=84860353308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860353308&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2011.10.019

DO - 10.1016/j.parkreldis.2011.10.019

M3 - Article

C2 - 22113132

AN - SCOPUS:84860353308

VL - 18

SP - 397

EP - 399

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 4

ER -